African nations have struggled to secure lifesaving COVID-19 vaccines, while rich nations have purchased more than they needed, depleting the global supply. High vaccine prices and intellectual property regulations that block the production of cheaper generics have contributed to a condition of African waithood. Hagan examines this waithood, which characterizes the disjuncture between African countries’ existential and humanitarian need for COVID-19 vaccines and corporations’ quest for profits in the pandemic. African waithood, produced by pharmaceutical companies including Moderna and Pfizer, is a direct product of colonialism. Waithood echoes the ongoing colonial relations between African nations and the corporations that continue to exploit them.